JP2022521240A5 - - Google Patents
Info
- Publication number
- JP2022521240A5 JP2022521240A5 JP2021548701A JP2021548701A JP2022521240A5 JP 2022521240 A5 JP2022521240 A5 JP 2022521240A5 JP 2021548701 A JP2021548701 A JP 2021548701A JP 2021548701 A JP2021548701 A JP 2021548701A JP 2022521240 A5 JP2022521240 A5 JP 2022521240A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- scfv
- seq
- baff
- igg4
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962808222P | 2019-02-20 | 2019-02-20 | |
| US62/808,222 | 2019-02-20 | ||
| PCT/US2020/019082 WO2020172440A1 (en) | 2019-02-20 | 2020-02-20 | Baff-r/cd19 targeted chimeric antigen receptor-modified t cells and use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022521240A JP2022521240A (ja) | 2022-04-06 |
| JP2022521240A5 true JP2022521240A5 (cg-RX-API-DMAC10.html) | 2023-02-13 |
| JP7593646B2 JP7593646B2 (ja) | 2024-12-03 |
Family
ID=69845600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021548701A Active JP7593646B2 (ja) | 2019-02-20 | 2020-02-20 | Ｂａｆｆ－ｒ／ｃｄ１９を標的としたキメラ抗原受容体修飾ｔ細胞とその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12545714B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3927738A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP7593646B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR20210129125A (cg-RX-API-DMAC10.html) |
| CN (1) | CN113874391B (cg-RX-API-DMAC10.html) |
| WO (1) | WO2020172440A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022515152A (ja) * | 2018-12-19 | 2022-02-17 | シティ・オブ・ホープ | Ｂａｆｆ－ｒ二重特異性ｔ細胞エンゲージャー抗体 |
| KR20210137085A (ko) | 2019-03-05 | 2021-11-17 | 엔카르타, 인크. | Cd19 유도된 키메라 항원 수용체 및 면역 요법에서 이의 용도 |
| WO2021163989A1 (en) * | 2020-02-21 | 2021-08-26 | Yinnuolai Biotech Ltd. | Anti-baff receptor antibodies and uses thereof |
| CA3203531A1 (en) | 2020-12-30 | 2022-07-07 | Simon Olivares | Recombinant vectors comprising polycistronic expression cassettes and methods of use thereof |
| CA3257911A1 (en) * | 2022-06-01 | 2023-12-07 | Seattle Children's Hospital D/B/A Seattle Children's Research Institute | Recombinant receptors binding to the B-cell activating factor receptor and their uses |
| US20260207667A1 (en) * | 2022-12-13 | 2026-07-23 | Juno Therapeutics, Inc. | Chimeric antigen receptors specific for baff-r and cd19 and methods and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9657105B2 (en) | 2013-03-15 | 2017-05-23 | City Of Hope | CD123-specific chimeric antigen receptor redirected T cells and methods of their use |
| DE102014105472B4 (de) | 2014-04-16 | 2016-03-17 | Sartorius Stedim Biotech Gmbh | Misch- und Auftauvorrichtung |
| US20170158749A1 (en) | 2014-04-23 | 2017-06-08 | Board Of Regents, The University Of Texas System | Chimeric antigen receptors (car) and methods for making and using the same |
| TWI751102B (zh) | 2014-08-28 | 2022-01-01 | 美商奇諾治療有限公司 | 對ｃｄ１９具專一性之抗體及嵌合抗原受體 |
| WO2016149578A1 (en) * | 2015-03-19 | 2016-09-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Dual specific anti-cd22-anti-cd19 chimeric antigen receptors |
| MX2018001568A (es) | 2015-08-07 | 2019-04-25 | Seattle Children´S Hospital Dba Seattle Children´S Res Institute | Celulas t biespecificas de receptor quimerico de antigeno (car) para focalizacion a tumores solidos. |
| EP3464371B1 (en) * | 2016-06-06 | 2026-07-29 | City of Hope | Baff-r targeted chimeric antigen receptor-modified t-cells and uses thereof |
| US11136405B2 (en) | 2016-06-06 | 2021-10-05 | Board Of Regents, The Unviersity Of Texas System | BAFF-R antibodies and uses thereof |
| CN108728459B (zh) | 2017-04-24 | 2023-08-04 | 上海恒润达生生物科技股份有限公司 | 靶向cd19的嵌合抗原受体并联合表达il-15的方法和用途 |
| AU2018269194B2 (en) * | 2017-05-15 | 2025-05-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Bicistronic chimeric antigen receptors and their uses |
| CN118853581A (zh) | 2017-06-21 | 2024-10-29 | 美商生物细胞基因治疗有限公司 | 嵌合抗原受体(CARs)、组合物及其使用方法 |
-
2020
- 2020-02-20 KR KR1020217029730A patent/KR20210129125A/ko active Pending
- 2020-02-20 JP JP2021548701A patent/JP7593646B2/ja active Active
- 2020-02-20 CN CN202080028641.1A patent/CN113874391B/zh active Active
- 2020-02-20 EP EP20712162.5A patent/EP3927738A1/en active Pending
- 2020-02-20 US US17/432,283 patent/US12545714B2/en active Active
- 2020-02-20 WO PCT/US2020/019082 patent/WO2020172440A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7241133B2 (ja) | Ｃｄ２０抗原を標的とするキメラ抗原受容体の構築およびその遺伝子改変ｔ細胞の活性同定 | |
| JP2025032091A5 (cg-RX-API-DMAC10.html) | ||
| JP2023139070A5 (cg-RX-API-DMAC10.html) | ||
| JP2020010699A5 (cg-RX-API-DMAC10.html) | ||
| JP2022527081A5 (cg-RX-API-DMAC10.html) | ||
| IL264144B2 (en) | Antibody 18A2 against CLAUDIN and its use | |
| JP2021531004A5 (cg-RX-API-DMAC10.html) | ||
| JP2020096630A5 (cg-RX-API-DMAC10.html) | ||
| JP2020513829A5 (cg-RX-API-DMAC10.html) | ||
| CA3032581A1 (en) | Treatment of cancer using a chimeric antigen receptor in combination with an inhibitor of a pro-m2 macrophage molecule | |
| JP2023514407A5 (cg-RX-API-DMAC10.html) | ||
| KR20220061982A (ko) | 키메라 항원 수용체 및 키메라 항원 수용체를 발현하는 면역 이펙터 세포 | |
| JP2020504723A5 (cg-RX-API-DMAC10.html) | ||
| JP2019537433A5 (cg-RX-API-DMAC10.html) | ||
| JP2025081512A5 (cg-RX-API-DMAC10.html) | ||
| JP2016514457A5 (cg-RX-API-DMAC10.html) | ||
| WO2019195408A1 (en) | Antibody variable domains targeting dll3, and use thereof | |
| JP2017522879A5 (cg-RX-API-DMAC10.html) | ||
| JP2023500338A (ja) | 多発性骨髄腫のｂｃｍａを標的としたｃａｒ－ｔ細胞療法 | |
| CN110157738B (zh) | 靶向cd19和cd22的工程化免疫细胞及其应用 | |
| CA3233246A1 (en) | Antibodies targeting baff-r and use thereof | |
| WO2020172641A1 (en) | Artificial immunosurveillance chimeric antigen receptor and cells expressing the same | |
| CN111587254A (zh) | 包含抗cd38和抗cd138嵌合抗原受体的t-细胞及其用途 | |
| US20220185882A1 (en) | Artificial immunosurveillance chimeric antigen receptor (ai-car) and cells expressing the same | |
| AU2016369623A1 (en) | Combination of c-Met inhibitor with antibody molecule to PD-1 and uses thereof |